A recent study concerning the utilization of cardiac stents has found that the stents are no more effective than medcines in preventing future heart attacks. However, the study was funded in part by pharmaceutical companies. This brings up a broader ethical issue concerning the objectivity of medical research, especially when that research is funded by organzations or companies that have a large financial stake in the study’s outcome.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.